Vaccine shows promise for Equine Strangles control

An international partnership of scientists from the Animal Health Trust (AHT), the Swedish University of Agricultural Sciences, the Karolinska Institute and Intervacc AB, have developed a new protein-based vaccine to protect horses from Strangles.

The disease is caused by the bacteria Streptococcus equi, which causes horses to suffer from large pus-filled abscesses in their throat and neck.

With an estimated 600 outbreaks of Strangles each year in the UK alone, the development of the new vaccine will have tremendous benefits to the health of horses around the world.

Click here to continue reading the article on the Labmate website.